As the Pass It On Network grows, so will the choice of activities. Our goal is to discover innovative programs, projects and ideas that generate and support active, productive, positive aging wherever they have been developed around the world, and to “pass them on” through our network for sharing and adapting. We seek out programs, projects and ideas that are relatively simple and inexpensive to try out.
We have organized our special interest groups (SIG), programs, projects & organizations, publications, and media along four pathways to Positive Ageing:
The Pass It On Network is very aware that we are all navigating unchartered territory meeting new challenges as they come up. One of the objectives is to work with scientific researchers to evaluate the efficacy of the Pass It On Network programs and www.passitonnetwork.org and report on the impact they are having.
One of the purposes our global program exchange is to learn from our experience and build on our skills. That is why we ask all Program Users to take the time to fill in the online Program Evaluation Form. We will be providing feedback to various organizations including:
- The International Longevity Centre-France
- The Institute for the Future
Progressively, we hope that programs will be inspired by research findings.
An example of how research can stimulate positive aging
Working Longer could stave off the onset of dementia. Baby boomers, take note: every year you put off retirement, your chances of developing Alzheimer’s disease or other types of dementia are cut by 3%. This is what research lead by the International Longevity Centre-France suggests. Intellectual stimulation and mental engagement throughout life may be protective against Alzheimer’s disease and other dementias. The findings of an analysis of the health and insurance records of more than 429,000 self-employed workers in France, were reported on at the Alzheimer’s Association International Conference (AAIC) in Boston in July 2013. Carole Dufouil, Ph.D., director of research in neuroepidemiology at INSERM (Institut National de la santé et de la recherché médicale) at the Bordeaux School of Public Health, was the spokesperson for the research team. See Abstract.